Final Results of Peginterferon Alfa-2b Add-on during Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients - a Multicenter Randomized Controlled Trial (PEGON Study)

被引：0
作者：
Chi, Heng [1 ]
Xie, Qing [2 ]
Zhang, Ning-Ping [3 ]
Qi, Xun [4 ]
Liang, Chen [4 ]
Guo, Simin [2 ]
Guo, Qing [2 ]
Arends, Pauline [1 ]
Wang, Jiyao [3 ]
Verhey, Elke [1 ]
de Knegt, Robert J. [1 ]
Hansen, Bettina E. [1 ]
Janssen, Harry L. [1 ,5 ]
机构：
[1] Erasmus MC Univ Med Ctr Rotterdam, Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Infect Dis, Shanghai 200030, Peoples R China
[3] Fudan Univ, Dept Gastroenterol & Hepatol, Zhongshan Hosp, Shanghai 200433, Peoples R China
[4] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Hepatitis Dis, Shanghai 200433, Peoples R China
[5] Univ Toronto, Toronto Gen & Western Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2002
引用
收藏
页码：1183A / 1183A
页数：1
相关论文
共 50 条
  • [41] LONG-TERM FOLLOW-UP OF PEGINTERFERON ALFA TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS IN PHASE III STUDY OF PEGINTERFERON ALFA-2b (40kD, Y SHAPE) (PEGBERON): A 4-YEAR FOLLOW-UP REPORT
    Wang, Guiqiang
    Hou, Fengqin
    Zhang, Min
    Shang, Jia
    Pan, Chen
    Lv, Hui
    Zhang, Mingxiang
    Peng, Yanzhong
    Xie, Qing
    Wang, Maorong
    Zhang, Dazhi
    Chen, Yongping
    Mao, Qianguo
    Liu, Jiajun
    Peng, Jie
    Mao, Qing
    Yang, Yongfeng
    Yin, Chibiao
    Han, Tao
    Cheng, Na
    Zhen, Zhen
    Zhang, Jiming
    Tan, Deming
    Chen, Liang
    Meng, Qinghua
    Wang, Hao
    Chen, Chengwei
    Li, Baosen
    Chen, Jun
    Yin, Yalin
    Sun, Li
    HEPATOLOGY, 2020, 72 : 488A - 489A
  • [42] Final results of the Australian prospective nucleos(t)ide analogue stop study: Long-term follow up identifies a higher incidence of functional cure in HBeAg-negative chronic hepatitis B
    Hume, Simon
    Hall, Sam
    Burns, Gareth
    Tassone, Daniel
    Desmond, Paul
    Ratnam, Dilip
    Sievert, William
    Levy, Miriam Tania
    Sawhney, Rohit
    Nicoll, Amanda
    Strasser, Simone
    Ngu, Meng
    Valaydon, Zina
    Sinclair, Marie
    Meredith, Christopher
    Matthews, Gail
    Vogrin, Sara
    Visvanathan, Kumar
    Holmes, Jacinta
    Thompson, Alexander
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 77 - 77
  • [43] New treatment strategy: switching from long-term entecavir to peginterferon alfa-2a induces HBeAg seroconversion/HBsAg clearance in patients with HBeAg-positive chronic hepatitis B
    Ning, Qin
    Han, Meifang
    Sun, Yongtao
    Jiang, Jia-ji
    Tan, Deming
    Hou, Jinlin
    Tang, Hong
    Sheng, Jifang
    Zhao, Mianzhi
    HEPATOLOGY, 2012, 56 : 300A - 301A
  • [44] Limited Sustained Response and Lack of HBsAg Decline after Stopping Long-Term Nucleos(t)Ide Analogue Therapy in Hbeag Negative Patients with Chronic Hepatitis B: Results of a Prospective, Randomized, Open-Label Phase IV Trial
    Liem, Kin Seng
    Fung, Scott K.
    Wong, David K. H.
    Yim, Colina K.
    Noureldin, Seham
    Huang, Feng Fei
    Shah, Hemant A.
    Feld, Jordan J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    HEPATOLOGY, 2018, 68 : 165A - 165A
  • [45] PEGINTERFERON ALFA-2A MONOTHERAPY AS A STRATEGY FOR ACHIEVING SUSTAINED RESPONSE IN PATIENTS SWITCHED FROM LONG-TERM NUCLEOS(T)IDE ANALOG THERAPY: THE RESULTS OF 1 YEAR FOLLOW UP
    Truong Ba Trung
    Pham Hoang Phiet
    HEPATOLOGY, 2011, 54 : 1026A - 1026A
  • [46]  HBeAg negative chronic hepatitis B patients with normal ALT and positive HBV DNA can benefit from nucleos(t)ide analogue therapy: results of a single center retrospective study with long-term follow-up
    Chen, En-Qiang
    Zhou, Jing
    Wang, Fa-Da
    Li, Lan-Qing
    GUT, 2023, 72 (SUPPL_1) : A159 - A159
  • [47] LONG-TERM ENTECAVIR TREATMENT FOR UP TO 5 YEARS IN ASIANS WITH HBEAG-POSITIVE NUCLEOS(T)IDE NAiVE CHRONIC HEPATITIS B: RESULTS FROM ETV-022 AND-901
    Pan, Calvin
    Tong, Myron J.
    Kowdley, Kris V.
    Hu, Ke-Qin
    Chang, Ting-Tsung
    Lai, Ching-Lung
    Yoon, Seung Kew
    Lee, Samuel S.
    Cohen, David S.
    Tang, Hong
    Tsai, Naoky C. S. C.
    HEPATOLOGY, 2010, 52 (04) : 557A - 557A
  • [48] Discontinuation of Effective Long-Term Nucleos(t)ide Analogue(s) [NA(s)] Treatment in HBeAg-Negative Chronic Hepatitis B (CHBe-) Patients: A Multicenter Ongoing Prospective Study
    Manolakopoulos, Spilios
    Kranidioti, Hariklia
    Kourikou, Anastasia
    Hadziyannis, Emilia
    Kontos, Georgios
    Deutsch, Melanie
    Alexopoulou, Alexandra
    Manesis, Emanuel K.
    Papatheodoridis, George V.
    HEPATOLOGY, 2015, 62 : 1193A - 1193A
  • [49] Discontinuation of Long-Term nucleos(t)ide Analogue(S) [Na(S)] Therapy in HBeAg-Negative Chronic Hepatitis B (CHBE-) Patients Without Cirrhosis: A Prospective Study
    Manolakopoulos, Spilios
    Kourikou, Anastasia
    Kranidioti, Hariklia
    Hadziyannis, Emilia
    Deutsch, Melanie
    Kontos, Georgios A.
    Alexopoulou, Alexandra
    Manesis, Emanuel K.
    Papatheodoridis, George V.
    GASTROENTEROLOGY, 2015, 148 (04) : S1068 - S1068
  • [50] Discontinuation of Long-Term Nucleos(T)Ide Analogue(S) [Na(S)] Therapy in HBeAg-Negative Chronic Hepatitis B (Chbe-) Patients Without Cirrhosis: A Prospective Study
    Manolakopoulos, Spilios
    Kranidioti, Hariklia
    Deutsch, Melanie
    Alexopoulou, Alexandra
    Kourikou, Anastasia
    Kontos, Georgios A.
    Manolakopoulos, Spilios
    Hadziyannis, Emilia
    Papatheodoridis, George V.
    GASTROENTEROLOGY, 2014, 146 (05) : S964 - S964
12345